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Abstract: A range of iridium(I) complexes of the type [Ir(cod)(NHC)PPh3)]X are reported, where the
N-heterocyclic carbene (NHC) is derived from the naturally-occurring imidaozlium salt, Lepidiline
A (1,3-dibenzyl-4,5-dimethylimidazolium chloride). A range of complexes were prepared, with a
number of NHC ligands and counter-ions, and various steric and electronic parameters of these
complexes were evaluated. The activity of the [Ir(cod)(NHC)PPh3)]X complexes in hydrogen isotope
exchange reactions was then studied, and compared to established iridium(I) complexes.
Keywords: iridium; N-heterocyclic carbene; hydrogen isotope exchange; deuterium
1. Introduction
Isotopically labelled compounds are of importance in a range of scientific disciplines. In particular,
the isotopes of hydrogen, deuterium, and tritium find application in several key areas. Within the
physical sciences, deuterated compounds are routinely used in the elucidation of reaction
mechanisms [1]. In the life sciences, deuterated and tritiated compounds are used to determine
the pharmacokinetic properties of bioactive molecules [2–4]. More recently, active pharmaceutical
ingredients themselves have begun to feature deuterium, exploiting the effect of relative C-H/C-D
bond strengths to deliver drug molecules with improved metabolic profiles [5,6].
Amongst the synthetic methods available for incorporation of deuterium or tritium into a molecule,
hydrogen isotope exchange (HIE) stands out due to its simplicity and generality [7–9]. A particularly
powerful variant of this process is directed HIE, whereby a Lewis basic group within the molecule
directs a metal catalyst to an adjacent site, and a subsequent C-H activation results in a metallocyclic
intermediate which facilitates HIE at this adjacent position (Scheme 1).
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Iridium(I) complexes are amongst the most effective metal catalysts for directed HIE [10] and,
in recent years, we have introduced a suite of highly active Ir(I) catalysts bearing a combination of
bulky phosphine and N-heterocyclic carbene ligands (Figure 1). These catalysts are compatible with a
broad variety of directing groups, enabling HIE on a wide range of substrates [11–18].
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groups at the heterocycle’s 4- and 5-positions [21] (Figure 2). We envisaged that this naturally-occurring
imidazolium salt could serve as a vehicle to begin to explore the effect of steric and electronic changes
in the NHC on the activity of our Ir(I) NHC/phosphine catalysts [22].
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2.1. Synthesis of Lepidiline A
Surprisingly, to our knowledge, no preparation of this naturally-occurring material has yet been
reported. Our synthetic route is summarised in Scheme 2. Chlorination of the commercially available
hydroxymethyl imidazolium salt 8 in neat thionyl chloride was easily achieved in excellent yield on a
multi-gram scale to deliver 9. Reduction and basification of 9 yielded the free 4,5-dimethylimidazole
10 with good levels of efficiency. Subsequently, double-alkylation of 10 under basic conditions could
be achieved using benzyl chloride to give Lepidiline A 3·HCl with good effectiveness, or with benzyl
bromide to give 3·HBr in excellent yield. Imidazolium bromide 3·HBr could then undergo salt
metathesis to very efficiently afford 3·HPF6 and 3·HBArF.
Catalysts 2020, 10, x FOR PEER REVIEW 3 of 11 
 
2.1. Synthesis of Lepidiline A 
Surprisingly, to our knowledge, no preparation of this naturally-occurring material has yet been 
reported. Our synthetic route is summarised in Scheme 2. Chlorination of the commercially available 
hydroxymethyl imidazolium salt 8 in neat thionyl chloride was easily achieved in excellent yield on 
a multi-gram scale to deliver 9. Reduction and basification of 9 yielded the free 4,5-dimethylimidazole 
10 with good levels of efficiency. Subsequently, double-alkylation of 10 under basic conditions could 
be achieved using benzyl chloride to give Lepidiline A 3·HCl with good effectiveness, or with benzyl 
bromide to give 3·HBr in excellent yield. Imidazolium bromide 3·HBr could then undergo salt 
metathesis to very efficiently afford 3·HPF6 and 3·HBArF. 
a
NHHN
Me OH
8
NHHN
Me Cl
9
b
N NH
Me Me
10
NN
MeMe
PhPh
Cl
cd
NN
MeMe
PhPh
Br
3·HCl
99% 87%
68%93%
e
f
99%
92% Lepidiline A
Cl Cl
3·HBr3·HBAr
F
3·HPF6
Conditions: (a) SOCl2 (neat) , 0 °C-rt, 4 h; (b) H2 (5 atm), Pd/C (10% w/w),
EtOH, 3 d, then K2CO3 (aq.); (c) NaH (1 eq.), BnCl (2.0 eq.), THF, reflux, 48 
h; (d) NaH (1 eq.), BnBr (2.1 eq.), THF, reflux, 4 h; (e) NH4PF6 (1.2 eq.),
MeOH/H2O (1:1), rt, 16 h; (f) NaBArF (1 eq.), DCM/H2O (1:1), rt, 16 h.  
Scheme 2. Synthesis of Lepidiline A and counter-ion analogues. 
Following the successful preparation of Lepidiline A 3·HCl and a range of its counterion 
derivatives, X-ray quality crystals of 3·HCl were grown and the structure solved to reveal a molecular 
footprint in direct agreement with the spectroscopic data and the reported natural product structure. 
The crystal structure was found to be a solvate containing one molecule of water per cation (Figure 
4, left). The same cationic motif was found in the X-ray structure of 3·HPF6. This latter structure has 
two crystallographically independent salt units per asymmetric unit (Z’ = 2). Both cations in this 
structure adopt anti conformations of the benzyl rings with respect to the heteroaromatic ring (Figure 
4, right). This is in contrast to the syn conformation found for 3·HCl and in the Ir complexes described 
below. 
  
Figure 4. Structures of Lepidiline A (left) and its PF6 derivative (right) as determined by single crystal 
diffraction. Atoms are shown as 50% probability ellipsoids. H atoms, disorder in the solvent, and 
anion of 3·HCl and the second independent cation-anion pair of 3·HPF6 have been omitted for clarity. 
c e e 2. S t esis of e i ili e a co ter-io a alog es.
l o ing the successful pre aration of Lepidiline A 3·HCl and a range of its counterion derivatives,
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The same cationic motif was found in the X-ray structure of 3·HPF6. This latter s ructu e has two
crystallographic lly indepe ent salt units per a ymmetric unit (Z’ = 2). Both cations in th s structure
adop anti conformati s of the benzyl rings with respect to the heteroaromatic ring (F gure 4, r ht).
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2.2. Preparation of Iridium Complexes Based on Lepidiline A 3
With a range of imidazolium salt precursors in hand, formation of the corresponding
iridium complexes was investigated. Based on work by Wang and Lin [25], and Liu et al. [26],
the [(cod)Ir(NHC)Cl] complexes can be prepared via a transmetallation procedure from the
corresponding silver bis-carbene complex. Employing the bromide salt 3·HBr, mixing with silver(I)
oxide and sodium iodide in dichloromethane gave silver complex 11 in high yield (Scheme 3).
This intermediate could be taken forward into a transmetallation procedure with [(cod)IrCl]2 13 to
provide the desired chloro-carbene complex 12 in excellent yield following a short reaction time.
Alternatively, it was also found that isolation of 11 could be circumvented via direct addition of
[(cod)IrCl]2 13 following in situ formation of the silver complex 11, delivering 12 in a further improved
overall yield. With this high-yielding method in place, X-ray quality crystals of 12 were grown,
confirming the proposed structure (Figure 5).
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for clarity.
With quant ties of the NHC chlori e compl x 12 s cur d, treatment with triphenylphosphine,
followed by silver h xafluorophosphate, eliver d targ t NHC-phosphine complex 6a in a good 75%
yield (Tabl 1, entry 1). In order to probe the effects of varying the counter-ion in these novel complexes,
derivatives 6b–6d were also prepared in an analogous manner and with excellent isolated yields
(Table 1, entries 2−4).
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Entry Complex X Yield
1 6a PF6 75
2 6b BF4 87
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e have previously shown that iridium NHC/phosphine complexes bearing a BArF (tetrakis
[3,5-bis(trifluoromethyl)phenyl]borate) counter-ion have a broader solvent applicability than the
corresponding PF6 complexes [13]. Based on this, BArF-containing complex 6e was prepared in a
one-pot procedure from [(cod)IrCl]2 13 in a good 82% yield (Scheme 4). Complexes 6a–6e were all
characterized by X-ray crystallography [23].
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l are often characterised by carbonylation of the complex, whereby t νCO stretching frequency
reports on the electron-donating nature of the other ligands on the metal [27]. Recent work on Ir(I)
dicarbonyl complexes has revealed that the configuration of the carbonyl ligands, though preferentially
cis, is dictated by the ligand size, with l rger combinations driving a trans dicarbonyl arrangement [28].
This structural fluidity limits the use of electronic param t rs derived from such complexes [28].
However, the synthesis and X-ra characterisation of t e c rbonlyated analogues f our NHC/phosphine
complexes could instead be us d t indicat a steric threshol —the ligand siz at which Ir(I) carbonyl
complexes switch fr m a cis- to a trans-configuration, and this could be correl ted with the well-known
steric parameter, p rcentage buried volume, %Vbur, [29] of the ligands.
Accordingly, we investigated the carbonylation of complexes 1a, 6a, and 7 (Scheme 5).
Direct exposure of complexes 6a and 7 t an atmosphere of CO resulted in complexes 14 and
15, where both the NHC/phosphine p ir and the two CO ligands are each cis-orientated, as shown by
t e X-ray crystal structures [23]. The c mbined ligand %Vbur values (Σ(%Vbur)) were similar for both
complexes, as determined by density functional theory (DFT) calculations (Table 2) [23]. As perhaps
expected, the enhanced bulk of the NHC ligand in 1a resulted in a complex, 16, with a trans-arrangement
of the NHC/P pair and of the two CO ligands, indicating the size and geometry of this co plex to be
quite distinct from the IBn and IBnMe analogues 14 and 15. Based on these parameters, there is little
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steric difference evident on moving from the IBn to IBnMe ligand, with the latter appearing to be a
very slightly bulkier system, based on the %Vbur values
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Table 2. Properties of Ir-carbonyl complexes 14–16.
Entry Complex N-Substituent R Yield %Vbur(PPh3) 2
%Vbur
(NHC) 2
Σ
(%Vbur)
θ (◦) 1
1 14 Bn H 49% 26.9 28.9 55.8 93.2
2 15 Bn Me 50% 27.0 29.2 56.2
89.4 3
92.6 3
3 16 Mes H 68% 27.9 32.6 60.5 160.0
1 θ represents the angle OC-Ir-CO. 2 Representative %Vbur values are calculated from DFT-optimized
[(NHC)(PPh3(Ir(H)2(DCM)2]+ complex cations. Full details are presented in the SI. 3 Carbonyl complex 15
crystallized with two different conformations.
Although these dicarbonyl complexes permitted only a steric, and not electronic, evaluation,
literature examples of Ir(I) chloro-carbonyl complexes have demonstrated that the combined influence
of various ligand partnerships on the metal’s pi-donating ability can be measured via IR spectroscopy,
based on the carbonyl stretching frequency, νCO [26,30]. Furthermore, the effect of the ligands on
the σ-donating nature of the complex can be measured by 1H nuclear magnetic resonance (NMR)
spectroscopic evaluation of the corresponding dihydride complexes [31]. The electronic characteristics of
the IMes, Ibn, and IBnMe ligands in our complexes were thus explored by preparing the chloro-carbonyl
complexes, 17–19 (Table 3). Additionally, from the NHC/PPh3 complexes, in situ generation of the
dihydride complexes 20–22, in CD3CN [23], provided insight into the σ-donating properties (Table 3).
Based on both electronic parameters, the IBnMe/PPh3 combination was found to be slightly more
electron-rich than IBn/PPh3,, and more significantly less electron-rich than IMes/PPh3.
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2.4. Evaluation of Iridium Complex Catalytic Activity in HIE
We next chose to focus on the relationship between the IBn/PPh3 and IBnMe/PPh3 complex pair
in terms of catalyst activity in HIE reactions. The two precatalysts 6a and 7 were compared via
kinetic analysis of the simple reference labelling reaction with acetophenone 23 (Table 4). Catalyst 6a,
derived from Lepidiline A, was clearly faster reacting, displaying a pseudo first order rate constant,
kobs(6a) = 0.0224 s−1, versus kobs(7) = 0.0145 s−1 for IBn/PPh3 catalyst 7 [23].
Table 4. Evaluation of complexes 6a and 7 in a benchmark HIE reaction.
Catalysts 2020, 10, x FOR PEER REVIEW 7 of 11 
 
Table 3. Electronic properties of Ir Cl/CO and dihydride complexes. 
 
Entry R R’ Cl/CO o plex ν(CO)DCM Dihydri e Co plex δH 
1 Bn H 17 1950 c −1 20 −21.35 pp  
2 Bn e 18 1948 c −1 21 −21.40 p  
3 es H 19 1942 c −1 22 −21.58 p  
2.4. Evaluation of Iridium Complex Catalytic Activity in HIE 
e next chose to focus on the relationship between the IBn/PPh3 and IBnMe/PPh3 co plex pair 
in ter s of catalyst activity in HIE reactions. The two precatalysts 6a and 7 were co pared via kinetic 
analysis of the si ple reference labelling reaction with acetophenone 23 (Table 4). Catalyst 6a, 
derived fro  Lepidiline A, was clearly faster reacting, displaying a pseudo first order rate constant, 
kobs(6a) = 0.0224 s−1, versus kobs(7) = 0.0145 s−1 for IBn/PPh3 catalyst 7 [23]. 
Table 4. Evaluation of complexes 6a and 7 in a benchmark HIE reaction. 
 
Entry Co plex NHC kobs 
1 6a IBnMe 0.0224 s−1 
2 7 IBn 0.0145 s−1 
This result was supported by DFT odelling of the turnover-li iting [12] C-H activation step 
(24 26, Sche e 6). Based on our electronic characterization of these co plexes, the greater reactivity 
of catalyst 6a over 7 can be rationalised on the basis of an increased π-donating ability of the Ir centre, 
and not on any appreciable steric difference between the two catalysts 6a and 7. 
Entry Complex NHC kobs
1 6a IBnMe .0224 s−1
2 7 IBn 0.0145 s−1
This result was supported by DFT modelling of the turnover-limiting [12] C-H activation step
(24→26, Scheme 6). Based on our electronic characterization of these complexes, the greater reactivity
of catalyst 6a over 7 can be rationalised on the basis of an increased pi-donating ability of the Ir centre,
and not on any appreciable steric difference between the two catalysts 6a and 7.
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when evaluating cou t r-ion effects with the IMes/PPh3 combination [13]. Presumably, th smaller
size of the IBnMe/PPh3 system suffers from competitive coordination of the triflate to the metal
centre [32]. Most curiously, th cataly t series 6 is ineffective at labelling the weakly coordinating
substrate, itrobenzene 30, whereas th flagship IMes/PPh3 ystem 1a labels to ~95% D under
similar conditions [11]. This may be due to diff rences in available intermolecular (for example pi-pi)
interactions of the substrate to the different catalyst systems upon binding. Nonetheless, such effects
hav the p tential t be expl ited favourably to ind ce directing group chemoselectivity in labelling
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Table 5. Evaluation of counter-ion effects in IBnMe/PPh3 complexes 6.
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3. Materials and Methods 
See the Supplementary Information for details of all experimental and computational 
procedures, as well as all crystallographic data. 
4. Conclusions 
In summary, the first synthesis of the simple imidazolium-based natural product, Lepidiline A, 
3·HCl, has been reported, along with a range of other counter-ion derivatives. This has been followed 
by the development of novel HIE catalysts and the use of a silver-NHC transmetallation approach to 
HIE catalyst synthesis. Detailed and combined experimental/computational analysis of the resulting 
iridium complexes 6 and 7 has led to quantitative insight into the parameters responsible for observed 
differences in the resulting catalytic reactivity of 6a versus the less substituted analogue, 7, and 
existing flagship HIE catalyst, 1a. Overall, dimethyl substitution on the backbone of the novel NHC 
was found to impart an electronic influence with a minimal impact on the steric environment. The 
reactivity differences between the catalysts studied are now being exploited in labelling 
regioselectivity studies, which will be reported in due course. 
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3. Materials and Methods
See the Supplementary Information for details of all experimental and computational procedures,
as well as all crystallographic data.
4. Conclusions
In summary, the first synthesis of the simple imidazolium-based natural product, Lepidiline A,
3·HCl, has been reported, along with a range of other counter-ion derivatives. This has been followed
by the development of novel HIE catalysts and the use of a silver-NHC transmetallation approach to
HIE catalyst synthesis. Detailed and combined experimental/computational analysis of the resulting
iridium complexes 6 and 7 has led to quantitative insight into the parameters responsible for observed
differences in the resulting catalytic reactivity of 6a versus the less substituted analogue, 7, and existing
flagship HIE catalyst, 1a. Overall, dimethyl substitution on the backbone of the novel NHC was found
to impart an electronic influence with a minimal impact on the steric environment. The reactivity
differences between the catalysts studied are now being exploited in labelling regioselectivity studies,
which will be reported in due course.
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